$3.24
0.01 (+0.46%)
Acura Pharmaceuticals Inc. (NASDAQ:ACUR)
CAPS Rating:
A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.
A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.